Slow-Release Jab Set To Transform Schizophrenia Treatment
A revolutionary schizophrenia treatment developed in Israel, which makes it easier for adult patients to manage their illness, has been granted approval by the US Food and Drug Administration, clearing the way for it to reach Americans in need as soon as this month. Pharmaceutical companies Teva of Israel and Medincell of France have teamed […]
May 15, 2023
European Firms, Accelerators Head To Tel Aviv With Over $300M To Invest In Israeli Startups
The 5th installment of the Europe Days conference will launch next week to leverage the huge business potential between Israel and Germany, Switzerland, and Austria.
March 13, 2019